Antiplatelet Effect of Melatonin through Breastfeeding: A Pediatric Case Report
- PMID: 38136041
- PMCID: PMC10741506
- DOI: 10.3390/children10121839
Antiplatelet Effect of Melatonin through Breastfeeding: A Pediatric Case Report
Abstract
We present a pediatric case of the antiplatelet effect of melatonin taken through breast milk in an 18-month-old child. The child was referred to our hematology outpatient clinic because of bleeding episodes that she presented since birth. Blood tests excluded the presence of blood coagulation diseases. The family history was negative for bleeding disorders. The child did not consume any drugs, food supplements, herbal teas or infusions. We performed an aggregation platelet test, which showed a reduced platelet aggregation. Shortly before, the baby had been breastfed. We speculated that breast milk could interfere with the result of the test; therefore, we decided to repeat the test in a fasting state. This time the test showed a normal platelet aggregation time. We learned that the child's mother was taking a mixture of valerian and melatonin. Thus, we decided to suspend maternal intake of melatonin and perform a new platelet aggregation test after three months. The test results were negative. After the suspension of melatonin, the patient did not present further bleeding events. In this case, melatonin, through the inhibition of platelet aggregation, had an important role on the hemostatic system of the child. Melatonin is considered as a dietary supplement and is mostly available as an alternative medicine without formal prescription and dosage regulation. It is important, especially during breastfeeding, to investigate personal and medication history, including also homeopathic remedies or dietary supplements.
Keywords: breastfeeding; melatonin; platelets.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.Pediatrics. 2003 Nov;112(5):e425. doi: 10.1542/peds.112.5.e425. Pediatrics. 2003. PMID: 14595087
-
In-vitro antiplatelet effect of melatonin in healthy individuals and patients with type 2 diabetes mellitus.J Endocrinol Invest. 2023 Dec;46(12):2493-2500. doi: 10.1007/s40618-023-02102-7. Epub 2023 May 6. J Endocrinol Invest. 2023. PMID: 37148530 Free PMC article.
-
Nutrition, growth, and allergic diseases among very preterm infants after hospital discharge.Dan Med J. 2013 Feb;60(2):B4588. Dan Med J. 2013. PMID: 23461996 Review.
-
Antiplatelet effect of aspirin in patients with coronary artery disease.Dan Med J. 2012 Sep;59(9):B4506. Dan Med J. 2012. PMID: 22951204 Review.
References
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources